Cargando…
Atopic Dermatitis: Striving for Reliable Biomarkers
Atopic dermatitis (AD) is a highly heterogeneous inflammatory disease regarding both its pathophysiology and clinical manifestations. However, it is treated according to the “one-size-fits-all” approach, which may restrict response to treatment. Thus, there is an unmet need for the stratification of...
Autores principales: | Mastraftsi, Styliani, Vrioni, Georgia, Bakakis, Michail, Nicolaidou, Electra, Rigopoulos, Dimitrios, Stratigos, Alexander J., Gregoriou, Stamatios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410433/ https://www.ncbi.nlm.nih.gov/pubmed/36012878 http://dx.doi.org/10.3390/jcm11164639 |
Ejemplares similares
-
The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review
por: Tsiogka, Aikaterini, et al.
Publicado: (2022) -
Atopic Dermatitis, food allergy and dietary interventions. A tale of
controversy ()
por: Guibas, George V., et al.
Publicado: (2013) -
The IL-4/-13 Axis and Its Blocking in the Treatment of Atopic Dermatitis
por: Pappa, Georgia, et al.
Publicado: (2022) -
Pruritogenic Mediators and New Antipruritic Drugs in Atopic Dermatitis
por: Koumaki, Dimitra, et al.
Publicado: (2023) -
Self-Esteem, Depression, Anxiety and Quality of Life in Patients with Melasma Living in a Sunny Mediterranean Area: Results from a Prospective Cross-Sectional Study
por: Platsidaki, Eftychia, et al.
Publicado: (2023)